# Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients

Study · id `cardio:ct-nct04818645` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04818645](<https://clinicaltrials.gov/study/NCT04818645>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04818645

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Heart rhythm problems; Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 477 participants.

## Technical summary

Registry record NCT04818645. Randomized; single masking; primary purpose prevention. Start 2023-01-31 (actual); primary completion 2028-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 477 participants (planned count; ClinicalTrials.gov record NCT04818645, source copy `cardio:ctgov-nct04818645-2026-03-23`, retrieved 2026-10-26)
- Started: 2023-01-31 (actual) (ClinicalTrials.gov record NCT04818645, source copy `cardio:ctgov-nct04818645-2026-03-23`, retrieved 2026-10-26)
- Primary completion: 2028-07-01 (anticipated) (ClinicalTrials.gov record NCT04818645, source copy `cardio:ctgov-nct04818645-2026-03-23`, retrieved 2026-10-26)
- Completion: 2028-07-01 (anticipated) (ClinicalTrials.gov record NCT04818645, source copy `cardio:ctgov-nct04818645-2026-03-23`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04818645, source copy `cardio:ctgov-nct04818645-2026-03-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04818645-2026-03-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients
- Acronym: ASSERT-AF
- Condition: Atrial Fibrillation
- Condition: Heart Failure
- Intervention (Device): ASSERT Insertable Cardiac Monitor
- Intervention (Other): Conventional Management and monitoring
- Lead sponsor: University of Rochester
- Lead sponsor class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: University of Rochester (`cardio:org-university-of-rochester`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: 8389757525f795e96711c8e2c4cb9489f7d03be0aaa857537c5c70a2e52e2026
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
